Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    (NCCAM) [SPONSOR-COLLABORATORS] (conjugated linoleic acid) [TREATMENT]
Show Display Options
Rank Status Study
1 Completed Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Rosiglitazone (Avandia) OR other diabetes medication currently prescribed to participant;   Dietary Supplement: conjugated linoleic acid (CLA)

Indicates status has not been verified in more than two years